T-Rex 2X Long MSTR Daily Target ETF (MSTU) Stock Price Today
Amgen downgraded after Novartis trial failure raises doubts on cholesterol drug prospects
Investment firm BMO Capital downgraded Amgen's stock from "Outperform" to "Market Perform" following a major clinical trial failure by Novartis for a similar cholesterol drug. Novartis' drug pelacarsen failed in a late-stage Phase III trial, casting ...
Medicus Pharma shifts focus to cancer drug CD228V, advancing melanoma trials and refining other drug programs.
Medicus Pharma is repositioning as a precision oncology biotech, prioritizing its cancer drug candidate CD228V targeting CD228-expressing solid tumors, with initial clinical trials focused on melanoma. The company sees melanoma, especially relapsed o...
Palantir's high valuation risks misreading its consulting-heavy business as pure software success.
Palantir's stock price has soared on strong AI-driven growth, but its business model leans more toward high-touch consulting than scalable software, raising valuation concerns. Despite impressive revenue growth and earnings beats, the company's relia...
Curaleaf rebuts Aurora's claims, defending its $5B acquisition offer as fair and beneficial for shareholders.
Curaleaf Holdings has released a detailed fact sheet countering Aurora Cannabis's criticisms of its $5 billion acquisition proposal. Curaleaf argues its offer includes one of the highest premiums in Canadian M&A history and highlights Aurora's poor f...
Intel shares jump 5% on leading High-NA EUV chip production milestone with ASML's support.
Intel's stock rose 5% following a milestone of processing over one million wafers using advanced High-NA EUV technology from ASML, positioning Intel years ahead in chip manufacturing innovation. ASML and Taiwan Semiconductor also gained 3% amid stron...
Verizon stock nears 52-week high with 29.5% gain; analysts see 11.6% more upside potential.
Verizon's stock has risen 29.5% this year, nearing its 52-week high, driven by six consecutive earnings beats and strong fiber growth. The company raised its 2026 earnings guidance and buyback target, signaling confidence in its turnaround. Analysts ...
SciBase secures $0.6M order to speed up clinical studies with Castle Biosciences on skin disease detection.
SciBase Holding AB has received an additional order worth approximately $0.6 million from Castle Biosciences to accelerate an ongoing clinical study and prepare for a second study. The collaboration focuses on using SciBase's AI-based Nevisense Go de...
Ramaco Resources execs to present at UBS and Jefferies investor conferences in NYC
Ramaco Resources announced that its senior management will participate in the UBS Global Materials Conference on September 9 and the Jefferies Global Industrials Conference on September 10 in New York City. CEO Randall Atkins and CFO Jeremy Sussman w...
Rocket Lab stock could more than double despite recent setbacks, says top Wall Street analyst.
Rocket Lab's stock trades at $64.26, well below the $111 average target, implying 72.7% upside. Despite a recent rocket test failure delaying the Neutron rocket's debut to late 2026 and causing a 14% drop in shares, the company has a strong $2.36 bil...
ADP expands partnership with AWS to enhance AI-driven HR and payroll solutions globally.
ADP and Amazon Web Services (AWS) have expanded their strategic partnership to combine ADP's 77 years of HR and payroll expertise with AWS's cloud and AI technologies. This collaboration aims to help ADP's 1.1 million clients across 140 countries man...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.